| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 84,907 | 101,098 | 106,136 | 106,852 | | Cost of Revenue | 25,425 | 24,573 | 26,551 | 39,442 | | | Gross Profit | 59,482 | 76,525 | 79,585 | 67,410 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,341 | 6,168 | 6,117 | 6,236 | | Non Recurring |
-
| (10,147) | 117,887 | 459,109 | | Others | 40,497 | 53,743 | 57,695 | 57,398 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,923 | 26,761 | (102,114) | (455,333) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,265 | 2,044 | 2,016 | 2,104 | | Earnings Before Interest And Taxes | 17,909 | 28,805 | (100,098) | (453,229) | | Interest Expense | 20,962 | 21,097 | 19,679 | 21,168 | | Income Before Tax | (3,053) | 7,708 | (119,777) | (474,397) | | Income Tax Expense | 9,247 | 24,865 | 841 | (45,194) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,300) | (17,157) | (120,618) | (429,203) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,300) | (17,157) | (120,618) | (429,203) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,300) | ($17,157) | ($120,618) | ($429,203) |
|
0.43% Nasdaq 
Income Statement
